Cargando…

Safety and pharmacokinetics of extended use of palivizumab in Saudi Arabian infants and children

BACKGROUND: The peak season of respiratory syncytial virus (RSV) infections in warmer climates may extend beyond the typical five-month RSV season of temperate regions. Additional monthly doses of palivizumab may be necessary in warmer regions to protect children at high risk for serious infection b...

Descripción completa

Detalles Bibliográficos
Autores principales:	al-Alaiyan, Saleh, Pollack, Paul, Notario, Gerard F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Just Medical Media Limited 2015
Materias:	Brief Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4353192/ https://www.ncbi.nlm.nih.gov/pubmed/25767550 http://dx.doi.org/10.7573/dic.212270

Ejemplares similares

Guidelines for palivizumab prophylaxis in infants and young children at increased risk for respiratory syncytial virus infection in Saudi Arabia
por: Al Aql, Fahad, et al.
Publicado: (2016)

Randomized, Double-Blind Study of the Safety of the Liquid Versus Lyophilized Formulation of Palivizumab in Premature Infants and Children with Chronic Lung Disease of Prematurity
por: Makari, Doris, et al.
Publicado: (2014)

Safety and Effectiveness of Palivizumab in Children at High Risk of Serious Disease Due to Respiratory Syncytial Virus Infection: A Systematic Review
por: Wegzyn, Colleen, et al.
Publicado: (2014)

Chemoprophylaxis of Neonatal Fungal Infections in Very Low Birth Weight Infants: Efficacy and Safety of Fluconazole and Nystatin
por: Al-Alaiyan, Saleh
Publicado: (2012)

Fortification with vitamin D: Comparative study in the Saudi Arabian and US markets
por: Sadat-Ali, Mir, et al.
Publicado: (2013)

Introducing the Comprehensive Unit-based Safety Program for mechanically ventilated patients in Saudi Arabian Intensive Care Units
por: Khan, Raymond M., et al.
Publicado: (2017)

Emerging variants of concern in Saudi Arabian SARS-CoV-2 isolates
por: Al-Sehemi, Abdullah G., et al.
Publicado: (2021)

Short-term outcome of very low-birth-weight infants in a tertiary care hospital in Saudi Arabia
por: Al Hazzani, Fahad, et al.
Publicado: (2011)

Aborting a Malformed Fetus: A Debatable Issue in Saudi Arabia: Retraction
por: Al-Alaiyan, Saleh
Publicado: (2014)

Randomized, Double-Blind Study of the Pharmacokinetics and Safety of Palivizumab Liquid Formulation Compared with Lyophilized Formulation
por: Robbie, Gabriel J., et al.
Publicado: (2014)

Safety Evaluation of Local Weight-Gain Formulas in the Saudi Arabian Markets
por: ALFaris, Nora Abdullah, et al.
Publicado: (2015)

The need for hospital-based neonatal palliative care programs in Saudi Arabia
por: Al-Alaiyan, Saleh, et al.
Publicado: (2009)

The effects of nursing work environment on patient safety in Saudi Arabian hospitals
por: AL-Dossary, Reem N.
Publicado: (2022)

Aerosol Delivery of Palivizumab in a Neonatal Lamb Model of Respiratory Syncytial Virus Infection
por: Edirisinghe, Hasindu S., et al.
Publicado: (2023)

Safety, efficacy and pharmacokinetics of palivizumab in off-label neonates, infants, and young children at risk for serious respiratory syncytial virus infection: a multicenter phase II clinical trial
por: Mori, Masaaki, et al.
Publicado: (2023)

Aborting a Malformed Fetus: A Debatable Issue in Saudi Arabia
por: Al-Alaiyan, Saleh, et al.
Publicado: (2012)

Effectiveness of Palivizumab in High-risk Infants and Children: A Propensity Score Weighted Regression Analysis
por: Anderson, Evan J., et al.
Publicado: (2017)

Genetic Subtypes and Natural Resistance Mutations in HCV Genotype 4 Infected Saudi Arabian Patients
por: Di Stefano, Mariantonietta, et al.
Publicado: (2021)

A Preliminary Report of Plastic Ingestion by Hawksbill and Green Turtles in the Saudi Arabian Red Sea
por: Tanabe, Lyndsey K., et al.
Publicado: (2023)

The Medicaid Cost of Palivizumab
por: Ambrose, Christopher S., et al.
Publicado: (2015)

A Randomized Controlled Trial to Compare Heated Humidified High-Flow Nasal Cannulae with Nasal Continuous Positive Airway Pressure Postextubation in Premature Infants: Retraction
por: Al-Alaiyan, Saleh
Publicado: (2014)

Exome sequencing of Saudi Arabian patients with ADPKD
por: Al-Muhanna, Fahad A., et al.
Publicado: (2019)

Saudi Arabian retinopathy of prematurity national telemedicine program: Achievements and challenges
por: Al Amro, Saleh A., et al.
Publicado: (2022)

Prevalence of diagnosed temporomandibular disorders among Saudi Arabian children and adolescents
por: Al-Khotani, Amal, et al.
Publicado: (2016)

Use of social media for the improvement of safety knowledge and awareness among Saudi Arabian phlebotomists
por: Attar, Razaz, et al.
Publicado: (2023)

Frequency of the frontal sinus aplasia among Saudi Arabian population. A single-center retrospective case review
por: Assiri, Kholood S., et al.
Publicado: (2021)

Is immunization with palivizumab really effective in high-risk children?
por: Raguž, Marjana Jerković, et al.
Publicado: (2023)

Botanical candidates from Saudi Arabian flora as potential therapeutics for Plasmodium infection
por: Al-Quraishy, Saleh, et al.
Publicado: (2021)

Use of social media for the improvement of radiation safety knowledge among Saudi Arabian radiographers
por: Hijlis, Shayma-a, et al.
Publicado: (2021)

Media use and behavioral disorders among Saudi Arabian children
por: Alghamdi, Salmah, et al.
Publicado: (2021)

Gastroenteritis attributable to rotavirus in hospitalized Saudi Arabian children in the period 2007–2008
por: Khalil, Mohamed, et al.
Publicado: (2015)

Attitude of Saudi Arabian adults towards consanguineous marriage
por: Alharbi, Omar A., et al.
Publicado: (2015)

A prospective, open-label, non-comparative study of palivizumab prophylaxis in children at high risk of serious respiratory syncytial virus disease in the Russian Federation
por: Turti, Tatyana V, et al.
Publicado: (2012)

Review of palivizumab in the prophylaxis of respiratory syncytial virus (RSV) in high-risk infants
por: Mejías, Asunción, et al.
Publicado: (2008)

Respiratory Syncytial Virus Infection in High-risk Infants – an Update on Palivizumab Prophylaxis
por: Resch, Bernhard
Publicado: (2014)

Assessing Variation in the Cost of Palivizumab for Respiratory Syncytial Virus Prevention in Preterm Infants
por: Shahabi, Ahva, et al.
Publicado: (2017)

Human respiratory syncytial virus and other viral infections in infants receiving palivizumab
por: Boivin, Guy, et al.
Publicado: (2008)

Risk factors for recurrent wheezing in preterm infants who received prophylaxis with palivizumab
por: Manini, Mariana Bueno, et al.
Publicado: (2021)

Utilization Management Opportunities for Palivizumab for Prophylaxis of Respiratory Syncytial Virus Complications in Infants
por: Curtiss, Frederic R., et al.
Publicado: (2010)

Nonketotic hyperglycinemia in Suleimaniah Children’s Hospital, Riyadh, Saudi Arabia
por: Roy, Devabrata, et al.
Publicado: (2004)

Cannot write session to /tmp/vufind_sessions/sess_di17qnullvolm5grfhgp30705t